Randolph C Read is Director of ENZON PHARMACEUTICALS, INC.. Currently has a direct ownership of 200,000 shares of ENZN, which is worth approximately $18,000. The most recent transaction as insider was on Jun 16, 2023, when has been sold 84,550 shares (Common Stock) at a price of $0.14 per share, resulting in proceeds of $11,837. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 200K
0% 3M change
0% 12M change
Total Value Held $18,000

RANDOLPH C READ Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2023
BUY
Open market or private purchase
$11,837 $0.14 p/Share
84,550 Added 29.71%
200,000 Common Stock
Jun 14 2023
BUY
Open market or private purchase
$1,950 $0.13 p/Share
15,000 Added 11.5%
115,450 Common Stock
Nov 18 2020
BUY
Open market or private purchase
$8,000 $0.16 p/Share
50,000 Added 33.23%
100,450 Common Stock
Nov 16 2020
BUY
Open market or private purchase
$7,568 $0.15 p/Share
50,450 Added 50.0%
50,450 Common Stock

Also insider at

SD
SANDRIDGE ENERGY INC Energy
RCR

Randolph C Read

Director
Oklahoma City, OK

Track Institutional and Insider Activities on ENZN

Follow ENZON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENZN shares.

Notify only if

Insider Trading

Get notified when an Enzon Pharmaceuticals, Inc. insider buys or sells ENZN shares.

Notify only if

News

Receive news related to ENZON PHARMACEUTICALS, INC.

Track Activities on ENZN